Command Palette

Search for a command to run...

ZOTA
1426.1(-2.18%)
1W: +3.58%

Zota Health Care Peer Comparison

Snapshot Summary

Zota Health Care Ltd. shows poor profitability and high levels of debt compared to its peers in the Pharmaceuticals & Drugs industry. However, its strong revenue growth indicates potential. Companies like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. stand out as strong performers, exhibiting solid profitability and reasonable valuations.

  • • Zota Health Care has the highest revenue growth YoY (28.96%) but the lowest profitability metrics (negative ROE and EPS).
  • • Cipla Ltd. and Dr. Reddy's Laboratories Ltd. are the most profitable peers with robust margins and returns, along with attractive valuations.
  • • Sun Pharmaceutical Industries Ltd. and Divi's Laboratories Ltd. appear overvalued relative to their growth and profitability metrics.
  • • Cipla Ltd.: Strong profitability metrics with a ROE of 16.63% and low valuation (PE of 23.73).
  • • Dr. Reddy's Laboratories Ltd.: Robust profitability with a ROE of 21.76% and a low PE ratio of 15.50.
  • • Mankind Pharma Ltd.: High revenue growth and strong profitability metrics, though slightly higher valuation.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
ZOTA--0.00-28.07%0.03
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.

Explore
Watchlists